𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong

✍ Scribed by Gannon C. Mak; Perrin W.W. Choy; W.Y. Lee; Ann H. Wong; K.C. Ng; Wilina Lim


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
86 KB
Volume
82
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

To study the serologic response to the new pandemic influenza A (H1N1) 2009 virus in Hong Kong, the level of immunity was measured before and after the occurrence of the outbreak, and the titer of antibody to the pandemic influenza A (H1N1) 2009 virus in serum samples of laboratory confirmed cases. The presence of pre‐outbreak pandemic influenza A (H1N1) 2009 virus antibodies in 37% of individuals older than >65 years suggested previous exposures to heterologous virus strains may have elicited cross‐reacting antibody. Following large outbreaks of pandemic influenza A 2009 virus that peaked in September 2009, there is a change in immunity level in various age groups consistent with the attack rates among population in Hong Kong. Among individuals with mild clinical presentation, the antibody response to pandemic influenza A (H1N1) 2009 virus was stronger in those individuals aged ≀24 years but took more time to reach a titer of 40 when compared with those aged >24 years; however, the antibody level declined slower among individuals aged ≀24 years. Regardless of age, the antibody response rose rapidly and reached much higher titer among individuals with severe clinical presentation. Further study is required to collect additional data on antibody persistence and determine how much protection is conferred by previous exposure to seasonal influenza A (H1N1) viruses. J. Med. Virol. 82:1809–1815, 2010. Β© 2010 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Immune response to pandemic H1N1 2009 in
✍ Wolfram Haller; Jim Buttery; Karen Laurie; Kathe Beyerle; Winita Hardikar; Georg πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 422 KB

After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromi

Viral load in patients infected with pan
✍ Kelvin K.W. To; Kwok-Hung Chan; Iris W.S. Li; Tak-Yin Tsang; Herman Tse; Jasper πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 104 KB πŸ‘ 1 views

Viral shedding profile of infections caused by the pandemic H1N1 2009 influenza A virus has not been reported. The aim of this study was to determine the viral load in different body sites. Viral loads of pandemic H1N1 virus in respiratory specimens, stool, urine, and serum were determined by quanti

Lymphocytopenia as a marker for pandemic
✍ Elena Chiappini; Luisa Galli; Alberta Azzi; Massimo Resti; Francesca Bonsignori; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Abstract Lymphocytopenia has been reported in adults with pandemic influenza A/H1N1 2009 infection, but data in children are inconclusive. Data from 76 children presented with flu‐like symptoms between July and November 2009 and tested for pandemic influenza A/H1N1 2009 virus and white blood cel

Viral load and epidemiological profile o
✍ Ana Beatriz Gorini da Veiga; NΓ©lson Alexandre Kretzmann; Laura Trevizan CorrΓͺa; πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 1 views

## Abstract Correlation between virologic profile and clinical features of patients infected by influenza virus provides important information for epidemiological control and clinical management of future disease outbreaks. Samples from patients in Southern Brazil, from June to December 2009, were

Development and comparison of molecular
✍ Wai-Yip Lam; Ting-Fan Leung; Nelson Lee; Jo L.K. Cheung; Apple C.M. Yeung; Yolan πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 1 views

## Abstract Human infection with the novel pandemic influenza A (H1N1) virus was first identified in April 2009. Two months later, the World Health Organization (WHO) had raised the pandemic level to phase 6. Rapid case identification is essential for prompt patient management and public health act